High Flow Nasal Cannula Compared to Standard Oxygen for Endoscopic Ultrasound
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: High flow nasal cannula.
- Who it may be relevant to
- Registry conditions: Endoscopic Ultrasound. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
High Flow Nasal Cannula Compared to Standard Oxygen Therapy for Endoscopic Ultrasound Procedure in High Risk Patients on Recovery Time and Procedural Conditions
Overview
The purpose of the study is to evaluate the use of high flow nasal cannula versus standard oxygen therapy for high-risk patients undergoing endoscopy procedures.
Detailed description
Patients with a higher BMI are at greater risk for lower oxygen levels which can delay the endoscopy procedure. This research is being conducted to find out if high risk patients will have a shorter recovery time and improved procedural conditions with a high flow nasal cannula versus standard oxygen therapy.
Interventions
- Other High flow nasal cannula
Subjects undergoing endoscopic ultrasound will receive high flow nasal cannula during the procedure
Primary outcome measures
- Decrease recovery time [Time frame: 4 hours]
Secondary outcome measures (1)
- Improve procedural conditions [Time frame: 1 hour]
Eligibility criteria
Inclusion criteria
- All patients age 18 years and older who present to Gonda 2 procedural area for Endoscopic ultrasound (EUS) with or without endoscopy (EGD)/biopsy/tissue sampling. with BMI ≥ 35 kg/m2 (BMI within the past 6 months in electronic medical records or at current procedure) who are able to consent will be approached for potential enrollment.
Exclusion criteria
- Need for general anesthesia for the procedure instead of the standard monitored anesthesia care.
- Patients undergoing combined procedure: Therapeutic EUS/combined procedures including EUS/ERCP, EUS/colonoscopy
- Patients on home oxygen therapy, or the diagnosis of "severe COPD"
- Patients with existing tracheostomy
- Inpatients undergoing EUS
- Inability to consent
- Cognitive impairment
- Blocked nasal passages
- Trauma/previous surgery to the nasopharynx
- Irregularities of the nose, face, or airway such that HFNC cannot be properly fitted
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Single blind
- Primary purpose
- Supportive care
Study locations
United States · 1 center
- Mayo Clinic — Rochester
Identifiers
NCT: NCT06704867 · 24-003924